Aurobindo Pharma Ltd - An Overview of Profitability

Case Code: FINC216 Case Length: 7 Pages Period: - Pub Date: 2025 Teaching Note: Available

Price: Rs.300 Organization: Aurobindo Pharma Industry: Pharmaceuticals & Biotech Countries: India Themes: Financial Analysis

Abstract Case Intro 1 Case Intro 2 Excerpts

Abstract

Aurobindo Pharma Limited, a leading Indian pharmaceutical company is ranked among the top 10 generic pharma companies in the world. It is an integrated large global pharmaceutical company with a presence in over 155 countries, with planned expansion into new territories such as Poland, Italy, Spain, the Czech Republic, Portugal, and France. Aurobindo Pharma became a public listed company in 1992. As of 2024, its market capitalization was US$ 8,565 million.

The management of the company initiated several measures to transform business operations to meet the ever changing market dynamics in India and across the globe. Of the major objectives Aurobindo Pharma planned to achieve during the fiscal year 2024-25, improving its operational performance was a key short-term one. The present case study helps in assessing the trend in the operational performance of Aurobindo Pharma using profitability ratios.

Issues

The case is structured to achieve the following teaching objectives:

• The process of analyzing and interpreting the profitability position of a company.
• The difference between various profitability ratios.
• The profitability position of Aurobindo Pharma Limited

Contents

Introduction
Expenses of Aurobindo Pharma Limited
Exhibits

Keywords

Profitability, Aurobindo Pharma, operating performance, Gross profit, Net profit Aurobindo Pharma, profit & loss account, Formulations, Pharma, overall profitability; profitability

Buy this case study (Please select any one of the payment options)

Price: Rs.300 Instant Download

Price: Rs.300 Express Checkout

PayPal (7 USD)